A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. - Ang YLE; Ho GF; Soo RA; Sundar R; Tan SH; Yong WP; Ow SGW; Lim JSJ; Chong WQ; Soe PP; Tai BC; Wang L; et al. (BMC cancer, 2020)